Additionally, the clinical phenotype and severity of MADD are thought to correlate with the ETF/ETFDH genotype, resulting in different levels of residual enzyme activity (19). The gene discussed is ETFDH; the disease is multiple acyl-CoA dehydrogenase deficiency.